1-3 of 3
John R. Wunderlich
Close
Sort by
Journal Articles

Tumor antigen–specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired

Mojgan Ahmadzadeh, Laura A. Johnson, Bianca Heemskerk, John R. Wunderlich, Mark E. Dudley, Donald E. White, Steven A. Rosenberg
Journal: Blood
Blood (2009) 114 (8): 1537–1544.
https://doi.org/10.1182/blood-2008-12-195792
Published: 2009
Journal Articles

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

Laura A. Johnson, Richard A. Morgan, Mark E. Dudley, Lydie Cassard, James C. Yang, Marybeth S. Hughes, Udai S. Kammula, Richard E. Royal, Richard M. Sherry, John R. Wunderlich, Chyi-Chia R. Lee, Nicholas P. Restifo, Susan L. Schwarz, Alexandria P. Cogdill, Rachel J. Bishop, Hung Kim, Carmen C. Brewer, Susan F. Rudy, Carter VanWaes, Jeremy L. Davis, Aarti Mathur, Robert T. Ripley, Debbie A. Nathan, Carolyn M. Laurencot, Steven A. Rosenberg
Journal: Blood
Blood (2009) 114 (3): 535–546.
https://doi.org/10.1182/blood-2009-03-211714
Published: 2009
Journal Articles

FOXP3 expression accurately defines the population of intratumoral regulatory T cells that selectively accumulate in metastatic melanoma lesions

Mojgan Ahmadzadeh, Aloisio Felipe-Silva, Bianca Heemskerk, Daniel J. Powell, Jr, John R. Wunderlich, Maria J. Merino, Steven A. Rosenberg
Journal: Blood
Blood (2008) 112 (13): 4953–4960.
https://doi.org/10.1182/blood-2008-06-163048
Published: 2008
Includes: Supplemental data